Here are three stocks with buy rank and strong value characteristics for investors to consider today, January 18th: DaVita DVA: This company which, operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S., carries a Zacks Rank #1(Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.4% over the last 60 days. DaVita Inc. Price and Consensus DaVita Inc. Price and Consensus DaVita Inc. price-consensus-chart | DaVita Inc. Quote DaVita has a price-to-earnings ratio (P/E) of 12.4 compared with 16.10 for the industry. The company possesses a Value Score of A. DaVita Inc. PE Ratio (TTM) DaVita Inc. PE Ratio (TTM) DaVita Inc. pe-ratio-ttm | DaVita Inc. Quote Cardinal Health CAH: This company which, is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days. Cardinal Health, Inc. Price and Consensus Cardinal Health, Inc. Price and Consensus Cardinal Health, Inc. price-consensus-chart | Cardinal Health, Inc. Quote Cardinal Health has a price-to-earnings ratio (P/E) of 15.41 compared with 26.60 for the industry. The company possesses a Value Score of A. Cardinal Health, Inc. PE Ratio (TTM) Cardinal Health, Inc. PE Ratio (TTM) Cardinal Health, Inc. pe-ratio-ttm | Cardinal Health, Inc. Quote Banco Bilbao Viscaya Argentaria BBVA: This company which, is engaged in a wide variety of banking, financial and related activities in Spain, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its next year earnings increasing 1.5% over the last 60 days. Banco Bilbao Viscaya Argentaria S.A. Price and Consensus Banco Bilbao Viscaya Argentaria S.A. Price and Consensus Banco Bilbao Viscaya Argentaria S.A. price-consensus-chart | Banco Bilbao Viscaya Argentaria S.A. Quote Banco Bilbao Viscaya Argentaria has a price-to-earnings ratio (P/E) of 6.02 compared with 8.50 for the industry. The company possesses a Value Score of A. Banco Bilbao Viscaya Argentaria S.A. PE Ratio (TTM) Banco Bilbao Viscaya Argentaria S.A. PE Ratio (TTM) Banco Bilbao Viscaya Argentaria S.A. pe-ratio-ttm | Banco Bilbao Viscaya Argentaria S.A. Quote See the full list of top ranked stocks here. Learn more about the Value score and how it is calculated here. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DaVita Inc. (DVA):Free Stock Analysis Report Cardinal Health, Inc. (CAH):Free Stock Analysis Report Banco Bilbao Viscaya Argentaria S.A. (BBVA):Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Best Value Stocks to Buy for January 18th
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...